Non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen and aspirin are widely used to treat pain and inflammation. But even at similar doses, different NSAIDs can have unexpected and unexplained effects on many diseases, including heart disease and cancer.
Now, a new study has uncovered a previously unknown process by which some NSAIDs affect the body. The finding may explain why similar NSAIDs produce a range of clinical outcomes and could inform how the drugs are used in the future. The study was published in the journal Immunity.
Until now, the anti-inflammatory effects of NSAIDs were believed to arise solely through the inhibition of certain enzymes. But this mechanism does not account for many clinical outcomes that vary across the family of drugs. For example, some NSAIDs prevent heart disease while others cause it, some NSAIDs have been linked to decreased incidence of colorectal cancer, and various NSAIDs can have a wide range of effects on asthma.
Now, using cell cultures and mice, the researchers have uncovered a distinct mechanism by which a subset of NSAIDs reduce inflammation. And that mechanism may help explain some of these curious effects.
The research showed that only some NSAIDs — including indomethacin, which is used to treat arthritis and gout, and ibuprofen — also activate a protein called nuclear factor erythroid 2-related factor 2, or NRF2, which, among its many actions, triggers anti-inflammatory processes in the body.
“It’s interesting and exciting that NSAIDs have a different mode of action than what was known previously,” said the lead author of the study. “And because people use NSAIDs so frequently, it’s important we know what they’re doing in the body.”
The research team can’t say for sure that NSAIDs’ unexpected effects are due to NRF2 — that will require more research. “But I think these findings are suggestive of that,” the author said.
The author is now looking into some of the drugs’ dermatological effects — causing rashes, exacerbating hives, and worsening allergies — and whether they are mediated by NRF2.
This discovery still needs to be confirmed in humans, the researchers note. But if it is, the findings could have impacts on how inflammation is treated and how NSAIDs are used.
For instance, several clinical trials are evaluating whether NRF2-activating drugs are effective in treating inflammatory diseases like Alzheimer’s disease, asthma, and various cancers; this research could inform the potential and limitations of those drugs. Additionally, NSAIDs might be more effectively prescribed going forward, with NRF2-activating NSAIDs and non-NRF2-activating NSAIDs applied to the diseases they’re most likely to treat.
The findings may also point to entirely new applications for NSAIDs, said the author.
NRF2 controls a large number of genes involved in a wide range of processes, including metabolism, immune response, and inflammation. And the protein has been implicated in aging, longevity, and cellular stress reduction.
https://www.cell.com/immunity/fulltext/S1074-7613(22)00186-8
Common painkillers activate gene expression to reduce inflammation
- 1,029 views
- Added
Latest News
Targeting bone marrow adipo…
By newseditor
Posted 03 Jul
Mapping the biology of spin…
By newseditor
Posted 03 Jul
Liver biopsy to predict pan…
By newseditor
Posted 03 Jul
Significant differences in…
By newseditor
Posted 02 Jul
Serotonin 2C receptor regul…
By newseditor
Posted 02 Jul
Other Top Stories
mRNA technology to target toxic tau
Read more
Magnesium transport 'pump' in cardiac function
Read more
Myelin producing cells linger unexpectedly before their death
Read more
Risk factors for faster aging in the brain
Read more
How the brain awakens from anesthesia
Read more
Protocols
Monitoring norepinephrine r…
By newseditor
Posted 01 Jul
BicemuS: A new tool for neu…
By newseditor
Posted 26 Jun
Deciphering spatial domains…
By newseditor
Posted 23 Jun
High-throughput volumetric…
By newseditor
Posted 21 Jun
Bioengineered human colon o…
By newseditor
Posted 14 Jun
Publications
Targeting adipocyte ESRRA p…
By newseditor
Posted 03 Jul
Stress-induced TDP-43 nucle…
By newseditor
Posted 03 Jul
Unraveling host regulation…
By newseditor
Posted 03 Jul
Propionic acid promotes neu…
By newseditor
Posted 03 Jul
Association of genetic risk…
By newseditor
Posted 03 Jul
Presentations
Myelin plasticity in the ve…
By newseditor
Posted 10 Jun
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar